Autonomix has created a first-in-class diagnostic tool that almost fits on the head of a pin. Paired with a catheter, their microchip can detect nerve signals that correspond with a wide range of disorders like hypertension, pain, heart problems, and more. Invest in Autonomix before their planned NASDAQ listing. Learn More
Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com. Musth Corp receives a fixed fee for each subscriber that clicks on a link in this email. See our disclaimer for further details.
With all of his many ventures, Mark Cuban, the celebrated billionaire investor who is set to sell a majority stake in the Dallas Mavericks, reportedly keeps to a routine to stay on top of his game. </ Continue Reading ➔
Microsoft just boosted its investment in OpenAI by as much as $10 billion. Here’s the “backdoor” way that you can join them as an AI investor in this red-hot space. Get the full story here
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Continue Reading ➔
U.S. stocks closed mixed in holiday-shortened trading session on Friday, ahead of the major shopping season. All three major indices, meanwhile, recorded their fourth straight weekly gains. Continue Reading ➔
Technology expert Ian King has found a way to invest in the technology powering AI energy. A breakthrough that presents a once-in-a-lifetime opportunity for fast-acting investors. Just go here for full details.
Last week, Nvidia Corporation (NASDAQ: NVDA) reported staggering third-quarter results. Despite its reliance on Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM), Nvidia’s Data Center division drove this impressive growth, Continue Reading ➔
Palantir Technologies, Inc (NYSE: PLTR) was falling slightly Monday after a 10% retracement between Tuesday and Friday last week dropped the stock from its 52-week high of $21.85. Continue Reading ➔
NEW YORK (AP) — After hearing from 40 witnesses over 2½ months, sounded almost wistful as he presided over the last day of testimony in Donald Trump’s . Continue Reading ➔
Some of America’s best “Doomsday” investors are buying one stock right now…and on January 30th, you’ll understand why. This stock has a track record of holding its own during bloodbaths. Get the ticker symbol
NVDA provides the entire stack of computing that allows for solid efficiencies and significant competitive advantages at the system level. Continue Reading ➔
ALBANY, N.Y. (AP) — Unpaid medical debt will no longer appear in New York residents’ credit reports under signed into law by Gov. Kathy Hochul on Wednesday. Continue Reading ➔
McDonald’s expects to open nearly 10,000 restaurants over the next four years, a pace of growth that would be unprecedented even for the world’s largest burger chain. Continue Reading ➔
Fisker Inc. (NYSE: FSR) announced Wednesday after the close of the market that Chairman and CEO Henrik Fisker issued a statement. Here is what to know. Continue Reading ➔
Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.